BANK OF HAWAII

Bank

Position in ABVX — Abivax S.A.

CIK 315080 HONOLULU, HI

Position in ABVX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$437,226

+$42,491 QoQ

Shares Held

3,281

-7.4% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#206

of 302 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BANK OF HAWAII holds $4,409,468 across 4 Biotechnology names. ABVX ranks #4 (9.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARWR	Arrowhead Pharmaceuticals, Inc.	29,276	$2,386,286
2	DNTH	Dianthus Therapeutics, Inc. /DE/	10,180	$992,346
3	REGN	Regeneron Pharmaceuticals, Inc.	952	$593,610
4	ABVX	Abivax S.A. This page	3,281	$437,226

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$437,226	3,281	-7.4%	Shares	Defined	2026-08-14
2026-03-31	$394,735	3,545	+2.6%	Shares	Defined	2026-05-15
2025-12-31	$465,789	3,454	+14.9%	Shares	Defined	2026-03-03
2025-09-30	$255,209	3,006	—	Shares	Defined	2025-11-14
No filing history on record for this holder in this stock.